Key result
Ambulatory cardiometabolic patients from the Americas without COVID-19 infection had lower-than-expected rates of influenza and pneumococcal vaccination during the pandemic.
Why the study?
Influenza and pneumococcus vaccinations are recommended for patients with cardiometabolic diseases, but immunization rates among ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas needed evaluation.
Cross-Sectional
Yes
During the COVID-19 pandemic, influenza and pneumococcal vaccination rates were lower than expected among ambulatory cardiometabolic patients in the Americas.
Raises concern for inadequate immunization in cardiometabolic patients; hypothesis-generating for targeted recovery strategies during disruptions.
BACKGROUND: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas. METHODS: Electronic surveys were collected from 13 Spanish speaking countries between 15 June and 15 July 2020. CONCLUSIONS: During the COVID-19 pandemic, ambulatory patients with cardiometabolic diseases from the Americas with no evidence of COVID-19 infection had lower-than-expected rates of IV and PV. Geographic, social, and cultural differences were found, and they should be explored in depth.
No takes yet. Share an insight, caveat, or question.
Liprandi et al. (2021) conducted a cross-sectional in Cardiometabolic diseases. Influenza and Pneumococcus vaccination was evaluated on Immunization rate (p=< 0.001). Ambulatory cardiometabolic patients from the Americas without COVID-19 infection had lower-than-expected rates of influenza and pneumococcal vaccination during the pandemic.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: